Dysplasia in Random Biopsies from Barrett’s Surveillance Is an Important Marker for More Severe Pathology
- 13 July 2020
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 66 (6) , 1957-1964
Abstract
Background and Aim Although endoscopic recognition of dysplasia in Barrett’s esophagus is difficult, experience in recognition of early neoplastic lesions is supposed to increase the detection of early neoplastic lesions. The aim of this study was to assess the significance of dysplasia in random biopsies in Barrett’s esophagus, in the absence of reported visible lesions as well as the difference in final outcome of pathology. Methods We retrospectively identified all patients with Barrett’s esophagus with suspicion of dysplasia or early adenocarcinoma who were referred to our center between February 2008 and April 2016. We analyzed all endoscopy reports, pathology reports, and referral letters from 19 different hospitals. Patients were divided into two groups, based on the presence or absence of visible lesions reported upon referral. Results In total, 170 patients diagnosed with dysplasia or adenocarcinoma were referred to our tertiary center. Ninety-one of these referred patients were referred with dysplasia or adenocarcinoma in random biopsies, without a reported lesion during endoscopy in the referral center. During endoscopic work-up at our center, a visible lesion was detected in 44 of these 91 patients (48.4%). After endoscopic work-up and treatment, adenocarcinoma was found in an additional 21 patients. Two of these patients were initially referred with low-grade dysplasia, and 19 patients were initially referred with high-grade dysplasia. The final pathology was upstaged in 35.8% of the patients. Conclusions The presence of any grade of dysplasia in random biopsies during surveillance in referral centers is a marker for more severe final pathology. Training in recognition of early neoplastic lesions in Barrett’s esophagus imaging is recommended for endoscopists performing Barrett’s surveillance.Keywords
This publication has 14 references indexed in Scilit:
- Computer-aided detection of early neoplastic lesions in Barrett’s esophagusEndoscopy, 2016
- Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progressionGut, 2015
- Detection and staging of esophageal cancers within Barrett's esophagus is improved by assessment in specialized Barrett's unitsGastrointestinal Endoscopy, 2014
- Surveillance of Barrett's Esophagus and Mortality from Esophageal Adenocarcinoma: A Population-Based Cohort StudyAmerican Journal of Gastroenterology, 2014
- The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysisGut, 2011
- Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patientsGut, 2010
- The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta-AnalysisAmerican Journal of Epidemiology, 2008
- Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagusGut, 2008
- The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M CriteriaGastroenterology, 2006
- The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colonGastrointestinal Endoscopy, 2003